在中文 olanzapine 稳定状态度的个体间变异性:探索代谢酶的单核酸多态性
Zhou Wan1,2, Yan-Nan Zang1,2, Fei Jia1,2
1The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
British journal of clinical pharmacology
|July 8, 2025
概括
个性化 olanzapine 治疗是关键,因为性,吸烟,炎症和其他药物等因素显著影响其稳定状态度. 了解这些变量有助于优化患者的剂量和结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 精神病学是一个精神病学.
背景情况:
- 奥兰扎平稳状态度表现出显著的个体间变化.
- 影响奥兰扎代谢的因素需要进一步阐明个性化剂量策略.
研究的目的:
- 为了研究生理因素,吸烟,炎症,并发药物和遗传多形态对奥兰扎平稳状态度的影响.
- 通过识别关键影响变量来指导个性化 olanzapine 剂量.
主要方法:
- 分析了310名接受过 olanzapine 治疗的患者的数据.
- 使用液体染色学-质谱学量化血清 olanzapine 度的量化.
- 在相关的代谢酶中识别单核酸多态 (SNP).
- 应用贝叶斯网络和g计算来确定因果关系并量化对剂量调整度 (C/D比率) 的因子影响.
主要成果:
- 贝叶斯网络分析表明,吸烟,性行为和同时使用塞特拉林,丹格伊-龙和酸与奥兰扎C/D比率之间存在因果关系.
- 证实多药和炎症会增加奥兰扎的C/D比率.
- 在男性和吸烟者中,G计算显示了 olanzapine C/D 比率的降低,以及使用 Danggui-Longhui,sertraline 和 valproic 酸.
结论:
- 性别,年龄,吸烟状况,炎症和同时使用特定药物 (塞特拉林,丹古伊-龙,烯酸) 显著导致奥兰扎度的变化.
- 将这些因素纳入临床实践可以促进个性化 olanzapine 治疗,特别是在亚洲患者群体.
相关概念视频
01:05Single Nucleotide Polymorphisms-SNPs
15.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.9K
01:12Analysis of Population Pharmacokinetic Data
394
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
394
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
305
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
305
02:26Comparing Copy Number Variations and SNPs
17.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
00:54Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
199
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
199
01:19Factors Affecting Drug Biotransformation: Biological
252
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
252